News

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
It's often been said that dogs see the world in black and white, but that's not exactly the case. The truth of the matter is ...
Ocugen has announced the US Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) amendment to ...
The OCU410ST Phase 2/3 pivotal confirmatory trial represents a major advancement as Ocugen's second late-stage clinical program. Ocugen plans to submit a BLA for OCU410ST in 2027 in alignment with its ...